Bortezomib

Bortezomib is used in the treatment of some types of cancers, specifically mantle cell lymphoma and multiple myeloma. The drug is an antineoplastic, thus it is used in chemotherapy. The drug blocks the function of some types of protein present in the cancer cell, which eventually destroys it.

Before you start Bortezomib, give your doctor a detailed medial history about any previous health conditions. Mention if you are suffering from any problems at the present. Provide him with a list of allergies, if you have any and also give him a list of medicines that you are taking.

Fluid intake should be increased once you start taking Bortezomib. Generally the drug is injected into a vein by a doctor or nurse.

Some common side effects that result because of Bortezomib are diarrhea, constipation, psychiatric disorders, nausea, anorexia, anemia and neuralgia. It can also lead to dizziness, weakness and changes in vision. Thus, driving should be avoided and it is best that you do not handle heavy machinery. Alcohol consumption should also be stopped while you are on Bortezomib. To prevent sudden bouts of dizziness moves slowly.

The drug also lowers the body’s ability to form blood clots. Hence, do not undertake any activity that may lead to a wound. Get in touch with your medical professional in case of excessive bleeding.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Mantle Cell Lymphoma

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Reduced Blood Platelets

• Psychiatric Disturbances

• Vomiting

• Nausea

• Loss Of Appetite

• Fever

• Anemia

• Diarrhoea

• Peripheral Neuropathy

• Decreased Appetite

• Low Energy

• Decreased White Blood Cell Count

• Constipation

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Is It safe with alcohol?

  Interaction with alcohol is unknown. Please consult your doctor.

• Are there any pregnancy warnings?

  Egybort 2mg injection is unsafe to use during pregnancy.
  There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.

• Are there any breast-feeding warnings?

  Egybort 2mg injection is probably unsafe to use during breastfeeding. Please consult your doctor.

• Is it safe to drive while on this medicine?

  Patients should avoid driving or using machines if they feel fatigue, dizziness, syncope, orthostatic/postural hypotension.

• Does this affect kidney function?

  There is no interaction between renal impairment and consuming this drug. So dose alteration is not needed.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Below is the list of medicines, which contains Bortezomib as ingredient

• Bortrac 2Mg Injection

  Glenmark Pharmaceuticals Ltd

• Ortez 2Mg Injection

  Zuventus Healthcare Ltd

• Bortenat 2Mg Injection

  Natco Pharma Ltd

• Bortetrust 2Mg Injection

  Panacea Biotec Ltd

• Egybort 2Mg Injection

  United Biotech Pvt Ltd

• Myezom 2Mg Injection

  Dr Reddy s Laboratories Ltd

• Bortenat 3.5Mg Injection

  Natco Pharma Ltd

• Bortemap 2Mg Injection

  RPG Life Sciences Ltd

• Myezom 3.5Mg Injection

  Dr Reddy s Laboratories Ltd

• Bortrac 3.5Mg Injection

  Glenmark Pharmaceuticals Ltd

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

Bortezomib is an antitumor agent which potently inhibits 26S proteasome and induces apoptosis in myeloma and leukemia cells. It also increases cancer cells sensitivity towards traditional anticancer agents and radiation.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Oncologist before using this medicine.

• Bortezomib-Drug Information Portal [Internet].druginfo.nlm.nih.gov 2022 [Cited 17 June 2022].Available from:

  https://druginfo.nlm.nih.gov/drugportal/name/bortezomib

• Bortezomib-DrugBank Online [Internet].go.drugbank.com 2022 [Cited 17 June 2022].Available from:

  https://go.drugbank.com/drugs/DB00188

• BORTEZOMIB injection,solution-DailyMed [Internet].dailymed.nlm.nih.gov 2022 [Cited 17 June 2022].Available from:

  https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=BORTEZOMIB